Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-29 @ 6:02 PM
Study NCT ID:
NCT06450366
Status:
COMPLETED
Last Update Posted:
2025-05-23
First Post:
2024-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of Enlicitide Decanoate (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018) CORALreef AddOn
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-08
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-28
Completion Date Type:
ACTUAL
First Submit Date:
2024-06-04
First Submit QC Date:
None
Study First Post Date:
2024-06-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-22
Last Update Post Date:
2025-05-23
Last Update Post Date Type:
ACTUAL